- Home
- Apac Radiotherapy Market
APAC radiotherapy market - Industry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-224 | No of pages: 241 | Format:
Asia-Pacific radiotherapy market is projected to register a CAGR of 6.8% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021, and the forecast period is 2022 to 2029.
Market Segmentation:
Asia Pacific Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software, Systemic Radiotherapy, Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, Vietnam and rest of Asia-Pacific), Industry Trends and Forecast to 2029
Some of the major factors contributing to the growth of the Asia-Pacific radiotherapy market are:
Use of radiotherapy treatment in wide cancer applications
Technology advancement in radiotherapy products
Market Players:
The key market players for the Asia-Pacific radiotherapy market are listed below:
CANON MEDICAL SYSTEMS CORPORATION
P-Cure
Mevion Medical Systems
VIEWRAY TECHNOLOGIES, INC. (VIEWRAY)
Elekta AB (pub)
Accuray Incorporated
IBA Worldwide
Eckert & Zeigler BEBIG
Xoft, a subsidiary of iCAD, Inc.
RaySearch Laboratories
Brainlab
Advanced Oncotherapy
Hitachi, LTD.
Advanced Accelerator Applications (A Subsidiary of Novartis AG)
Sumitomo Heavy Industries, Ltd.
Siemens Healthcare GmbH
Koninklijke Philips N.V.
Panacea Medical Technologies Pvt. Ltd.
ZEISS International
General Electric Company
SIT-S.I.T. Sordina IORT Technologies S.p.A.
CIVCO Radiotherapy
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 41
1.1 OBJECTIVES OF THE STUDY 41
1.2 MARKET DEFINITION 41
1.3 OVERVIEW OF ASIA PACIFIC RADIOTHERAPY MARKET 41
1.4 LIMITATIONS 43
1.5 MARKETS COVERED 43
2 MARKET SEGMENTATION 46
2.1 MARKETS COVERED 46
2.2 GEOGRAPHICAL SCOPE 47
2.3 YEARS CONSIDERED FOR THE STUDY 48
2.4 CURRENCY AND PRICING 48
2.5 DBMR TRIPOD DATA VALIDATION MODEL 49
2.6 MULTIVARIATE MODELLING 52
2.7 TYPE LIFELINE CURVE 52
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
2.9 DBMR MARKET POSITION GRID 54
2.10 VENDOR SHARE ANALYSIS 56
2.11 MARKET APPLICATION COVERAGE GRID 57
2.12 SECONDARY SOURCES 58
2.13 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 62
4.1 PESTEL ANALYSIS 64
4.2 PORTER'S 5 FORCES 65
5 REGULATIONS 66
5.1 BRACHYTHERAPY DEVICES REGULATIONS: 66
5.2 USE OF SOURCES FOR MANUAL BRACHYTHERAPY. 66
5.3 BRACHYTHERAPY SOURCES ACCOUNTABILITY. 66
5.4 EUROPE MEDICAL AGENCY REGULATION 67
5.5 UK 67
5.6 INDIA: 68
6 MARKET OVERVIEW 69
6.1 DRIVERS 71
6.1.1 GROWING PREVALENCE OF CANCER DISEASE 71
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT 75
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES 76
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES 76
6.2 RESTRAINTS 77
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 77
6.2.2 COMPLEX NATURE OF RADIOTHERAPY 77
6.2.3 HIGH COST OF RADIOTHERAPY PROCEDURE 78
6.3 OPPORTUNITIES 78
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT 78
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARDS CANCER TREATMENT 81
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT 81
6.4 CHALLENGES 82
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS 82
6.4.2 RISK OF RADIATION EXPOSURE 83
7 IMPACT OF COVID-19 ON ASIA PACIFIC RADIOTHERAPY MARKET 84
7.1 IMPACT ANALYSIS ON DEMAND 84
7.2 CONCLUSION 84
8 ASIA PACIFIC RADIOTHERAPY MARKET, BY TYPE 85
8.1 OVERVIEW 86
8.2 EXTERNAL-BEAM RADIATION THERAPY 89
8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT) 90
8.2.2 PROTON BEAM THERAPY 90
8.2.3 STEREOTACTIC RADIATION THERAPY 90
8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT) 90
8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT) 90
8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT) 90
8.2.7 OTHERS 91
8.3 INTERNAL RADIATION THERAPY 91
8.3.1 BRACHYTHERAPY 92
8.3.1.1 HIGH DOSE BRACHYTHERAPY 92
8.3.1.2 LOW DOSE BRACHYTHERAPY 92
8.3.2 SELECTIVE INTERNAL RADIATION THERAPY (SIRT) 92
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS 93
8.5 OTHERS 93
9 ASIA PACIFIC RADIOTHERAPY MARKET, BY PRODUCT 95
9.1 OVERVIEW 96
9.2 EXTERNAL BEAM RADIATION THERAPY 99
9.2.1 LINAC 100
9.2.2 PROTON THERAPY 100
9.2.2.1 SYNCHROTRON 100
9.2.2.2 CYCLOTRON 100
9.2.3 CYBER KNIFE 100
9.2.4 GAMMA KNIFE 101
9.2.5 OTHERS 101
9.3 INTERNAL RADIOTHERAPY PRODUCTS 101
9.3.1 SEEDS 102
9.3.2 ELECTRONIC BRACHYTHERAPY 102
9.3.3 APPLICATORS 102
9.3.4 AFTERLOADERS 102
9.3.5 OTHERS 102
9.4 RADIOTHERAPY SOFTWARE 102
9.4.1 IMAGE GUIDING SOFTWARE 103
9.4.2 TREATMENT PLANNING SOFTWARE 103
9.4.3 PATIENT POSITIONING SOFTWARE 103
9.4.4 DOSAGE PLANNING SOFTWARE 104
9.4.5 OTHERS 104
9.5 SYSTEMIC RADIOTHERAPY 104
9.5.1 ALPHA EMITTERS 105
9.5.2 BETA EMITTERS 105
9.6 OTHERS 105
10 ASIA PACIFIC RADIOTHERAPY MARKET, BY APPLICATION 106
10.1 OVERVIEW 107
10.2 BREAST CANCER 111
10.3 LUNG CANCER 112
10.4 PROSTATE CANCER 113
10.5 COLORECTAL CANCER 114
10.6 LYMPHOMA 115
10.7 LIVER CANCER 116
10.8 THYROID CANCER 117
10.9 BRAIN CANCER 117
10.10 CERVICAL CANCER 118
10.11 SPINE CANCER 119
10.12 OTHERS 120
11 ASIA PACIFIC RADIOTHERAPY MARKET, BY END USER 121
11.1 OVERVIEW 122
11.2 HOSPITALS 125
11.3 RADIATION THERAPY CENTERS 125
11.4 SPECIALTY CLINICS 126
11.5 OTHERS 127
12 ASIA PACIFIC RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL 128
12.1 OVERVIEW 129
12.2 DIRECT TENDER 132
12.3 RETAIL SALES 132
12.4 OTHERS 133
13 ASIA PACIFIC RADIOTHERAPY MARKET, BY REGION 134
13.1 ASIA-PACIFIC 135
13.1.1 CHINA 143
13.1.2 JAPAN 147
13.1.3 INDIA 151
13.1.4 AUSTRALIA 155
13.1.5 SOUTH KOREA 159
13.1.6 SINGAPORE 163
13.1.7 MALAYSIA 167
13.1.8 INDONESIA 171
13.1.9 THAILAND 175
13.1.10 PHILIPPINES 179
13.1.11 VIETNAM 183
13.1.12 REST OF ASIA-PACIFIC 187
14 ASIA PACIFIC RADIOTHERAPY MARKET: COMPANY LANDSCAPE 188
14.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC 188
15 SWOT ANALYSIS 189
16 COMPANY PROFILE 190
16.1 SIEMENS HEALTHCARE GMBH 190
16.1.1 COMPANY SNAPSHOT 190
16.1.2 REVENUE ANALYSIS 190
16.1.3 COMPANY SHARE ANALYSIS 191
16.1.4 PRODUCT PORTFOLIO 191
16.1.5 RECENT DEVELOPMENT 192
16.2 ELEKTA AB (PUB) 193
16.2.1 COMPANY SNAPSHOT 193
16.2.2 RECENT FINANCIALS 193
16.2.3 COMPANY SHARE ANALYSIS 194
16.2.4 PRODUCT PORTFOLIO 194
16.2.5 RECENT DEVELOPMENT 195
16.3 ACCURAY INCORPORATED 196
16.3.1 COMPANY SNAPSHOT 196
16.3.2 RECENT FINANCIALS 196
16.3.3 COMPANY SHARE ANALYSIS 197
16.3.4 PRODUCT PORTFOLIO 197
16.3.5 RECENT DEVELOPMENT 197
16.4 GENERAL ELECTRIC COMPANY 198
16.4.1 COMPANY SNAPSHOT 198
16.4.2 REVENUE ANALYSIS 198
16.4.3 COMPANY SHARE ANALYSIS 199
16.4.4 PRODUCT PORTFOLIO 199
16.4.5 RECENT DEVELOPMENT 199
16.5 IBA WORLDWIDE 200
16.5.1 COMPANY SNAPSHOT 200
16.5.2 RECENT FINANCIALS 200
16.5.3 COMPANY SHARE ANALYSIS 201
16.5.4 PRODUCT PORTFOLIO 201
16.5.5 RECENT DEVELOPMENT 201
16.6 ADVANCED ACCELERATOR APPLICATIONS (A SUBSIDIARY OF NOVARTIS AG) 202
16.6.1 COMPANY SNAPSHOT 202
16.6.2 REVENUE ANALYSIS 202
16.6.3 PRODUCT PORTFOLIO 203
16.6.4 RECENT DEVELOPMENT 203
16.7 ADVANCED ONCOTHERAPY 204
16.7.1 COMPANY SNAPSHOT 204
16.7.2 PRODUCT PORTFOLIO 204
16.8 ARIANE MEDICAL SYSTEMS LTD 205
16.8.1 COMPANY SNAPSHOT 205
16.8.2 PRODUCT PORTFOLIO 205
16.8.3 RECENT DEVELOPMENT 205
16.9 BRAINLAB 206
16.9.1 COMPANY SNAPSHOT 206
16.9.2 PRODUCT PORTFOLIO 206
16.9.3 RECENT DEVELOPMENT 206
16.10 CANON MEDICAL SYSTEMS CORPORATION 207
16.10.1 COMPANY SNAPSHOT 207
16.10.2 PRODUCT PORTFOLIO 207
16.10.3 RECENT DEVELOPMENT 207
16.11 CIVCO RADIOTHERAPY 208
16.11.1 COMPANY SNAPSHOT 208
16.11.2 PRODUCT PORTFOLIO 208
16.11.3 RECENT DEVELOPMENT 209
16.12 ECKERT & ZIEGLER BEBIG 210
16.12.1 COMPANY SNAPSHOT 210
16.12.2 RECENT FINANCIALS 210
16.12.3 PRODUCT PORTFOLIO 211
16.12.4 RECENT DEVELOPMENT 211
16.13 HITACHI, LTD. 212
16.13.1 COMPANY SNAPSHOT 212
16.13.2 REVENUE ANALYSIS 212
16.13.3 PRODUCT PORTFOLIO 213
16.13.4 RECENT DEVELOPMENT 213
16.14 INTRAOP MEDICAL, INC. 214
16.14.1 COMPANY SNAPSHOT 214
16.14.2 PRODUCT PORTFOLIO 214
16.14.3 RECENT DEVELOPMENT 215
16.15 ISORAY INC. 216
16.15.1 COMPANY SNAPSHOT 216
16.15.2 REVENUE ANALYSIS 216
16.15.3 PRODUCT PORTFOLIO 217
16.15.4 RECENT DEVELOPMENT 217
16.16 KONINKLIJKE PHILIPS N.V. 218
16.16.1 COMPANY SNAPSHOT 218
16.16.2 REVENUE ANALYSIS 218
16.16.3 PRODUCT PORTFOLIO 219
16.16.4 RECENT DEVELOPMENT 219
16.17 MEVION MEDICAL SYSTEMS 220
16.17.1 COMPANY SNAPSHOT 220
16.17.2 PRODUCT PORTFOLIO 220
16.17.3 RECENT DEVELOPMENT 220
16.18 MIRADA MEDICAL LIMITED 221
16.18.1 COMPANY SNAPSHOT 221
16.18.2 PRODUCT PORTFOLIO 221
16.18.3 RECENT DEVELOPMENT 221
16.19 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH) 222
16.19.1 COMPANY SNAPSHOT 222
16.19.2 REVENUE ANALYSIS 222
16.19.3 PRODUCT PORTFOLIO 223
16.19.4 RECENT DEVELOPMENT 223
16.20 PANACEA MEDICAL TECHNOLOGIES PVT. LTD. 224
16.20.1 COMPANY SNAPSHOT 224
16.20.2 PRODUCT PORTFOLIO 224
16.20.3 RECENT DEVELOPMENT 224
16.21 P-CURE 225
16.21.1 COMPANY SNAPSHOT 225
16.21.2 PRODUCT PORTFOLIO 225
16.21.3 RECENT DEVELOPMENT 225
16.22 PROTOM INTERNATIONAL 226
16.22.1 COMPANY SNAPSHOT 226
16.22.2 PRODUCT PORTFOLIO 226
16.22.3 RECENT DEVELOPMENT 226
16.23 PROVISION HEALTHCARE 227
16.23.1 COMPANY SNAPSHOT 227
16.23.2 PRODUCT PORTFOLIO 227
16.23.3 RECENT DEVELOPMENT 227
16.24 RAYSEARCH LABORATORIES 228
16.24.1 COMPANY SNAPSHOT 228
16.24.2 REVENUE ANALYSIS 228
16.24.3 PRODUCT PORTFOLIO 229
16.24.4 RECENT DEVELOPMENT 229
16.25 SIT - S.I.T. SORDINA IORT TECHNOLOGIES S.P.A. 230
16.25.1 COMPANY SNAPSHOT 230
16.25.2 PRODUCT PORTFOLIO 230
16.26 SUMITOMO HEAVY INDUSTRIES, LTD. 231
16.26.1 COMPANY SNAPSHOT 231
16.26.2 REVENUE ANALYSIS 231
16.26.3 PRODUCT PORTFOLIO 232
16.26.4 RECENT DEVELOPMENT 232
16.27 VIEWRAY TECHNOLOGIES, INC. (VIEWRAY) 233
16.27.1 COMPANY SNAPSHOT 233
16.27.2 RECENT FINANCIALS 233
16.27.3 PRODUCT PORTFOLIO 234
16.27.4 RECENT DEVELOPMENT 234
16.28 XOFT, A SUBSIDIARY OF ICAD, INC. 235
16.28.1 COMPANY SNAPSHOT 235
16.28.2 REVENUE ANALYSIS 235
16.28.3 PRODUCT PORTFOLIO 236
16.28.4 RECENT DEVELOPMENT 236
16.29 ZEISS INTERNATIONAL 237
16.29.1 COMPANY SNAPSHOT 237
16.29.2 PRODUCT PORTFOLIO 237
16.29.3 RECENT DEVELOPMENT 237
17 QUESTIONNAIRE 238
18 RELATED REPORTS 241
Segmentation
Short Description
Asia-Pacific Radiotherapy Market, By Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, Others), Product (External Beam Radiotherapy, Internal Radiotherapy Products, Radiotherapy Software, Systemic Radiotherapy Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, Vietnam and Rest of Asia-Pacific), Industry Trends and Forecast to 2029
Market Definition
Radiotherapy is a type of treatment procedure that is mainly used to treat cancer disease by the usage of X-rays and similar forms of radiation technology. The method and procedure of radiotherapy have been advanced in terms of launching new treatment planning software and advanced features-based therapy modalities.
In radiotherapy treatment, high-energy based radiation rays are often used to damage cancer cells and stop them from growing and dividing. External radiation therapy has numerous types of advanced technology which is used in the treatment of cancer. External radiation therapy comprised of three-dimensional conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), proton beam therapy, image-guided radiation therapy (IGRT), stereotactic radiation therapy, and volumetric modulated ARC therapy (VMAT), among others.
Market Segmentation
Asia-Pacific radiotherapy market is categorized into five notable segments which are based on type, product, application, end user, and distribution channel.
On the basis of type, the Asia-Pacific radiotherapy market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/radiopharmaceuticals, and others
On the basis of product, the Asia-Pacific radiotherapy market is segmented into external beam radiotherapy, internal radiotherapy products, radiotherapy software, systemic radiotherapy, and others
On the basis of application, the Asia-Pacific radiotherapy market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others
On the basis of end user, the Asia-Pacific radiotherapy market is segmented into hospitals, radiation therapy centers, specialty clinics, and others
On the basis of distribution channel, the Asia-Pacific radiotherapy market is segmented into direct tender, retail sales, and others
Market Players
The key market players for the Asia-Pacific radiotherapy market are listed below:
CANON MEDICAL SYSTEMS CORPORATION
P-Cure
Mevion Medical Systems
VIEWRAY TECHNOLOGIES, INC. (VIEWRAY)
Elekta AB (pub)
Accuray Incorporated
IBA Worldwide
Eckert & Zeigler BEBIG
Xoft, a subsidiary of iCAD, Inc.
RaySearch Laboratories
Brainlab
Advanced Oncotherapy
Hitachi, LTD.
Advanced Accelerator Applications (A Subsidiary of Novartis AG)
Sumitomo Heavy Industries, Ltd.
Siemens Healthcare GmbH
Koninklijke Philips N.V.
Panacea Medical Technologies Pvt. Ltd.
ZEISS International
General Electric Company
SIT-S.I.T. Sordina IORT Technologies S.p.A.
CIVCO Radiotherapy
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.